Loading company…
Zikani Therapeutics develops novel antibiotic compounds for serious infections and rare diseases at a preclinical stage.
Founded in 2014 and based in Massachusetts, US, Zikani Therapeutics, Inc., formerly known as Macrolide Pharmaceuticals, Inc., is a preclinical-stage company. It focuses on novel antibiotic compounds to relieve patient suffering from serious infections and rare diseases. It is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in